Ovaleap is a medicine used in assisted reproduction treatments in the following cases:
- Women who suffer from anovulation or who are diagnosed with polycystic ovary syndrome (PCOS).
- Women undergoing ovarian stimulation during IVF
- Women with severe LH and FSH deficiency. In this case, Ovaleap is administered in combination with an LH preparation for ovarian stimulation.
Read the full article on: Ovaleap in IVF: Administration, Costs & Possible Side Effects ( 80).
Zaira Salvador
B.Sc., M.Sc.
Bachelor's Degree in Biotechnology from the Technical University of Valencia (UPV). Biotechnology Degree from the National University of Ireland en Galway (NUIG) and embryologist specializing in Assisted Reproduction, with a Master's Degree in Biotechnology of Human Reproduction from the University of Valencia (UV) and the Valencian Infertility Institute (IVI)
License: 3185-CV
